Company intelligence / Profile preview
CTEX
Hyogo, Japanc-tex.jp ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CTEX is a Japan-based regenerative medicine company spun out of Hyogo Medical University to develop and support cell therapies originating from academia. The company is focused on amniotic mesenchymal stem cell-based regenerative medicine and angiogenesis approaches, and is also commercializing NeoSERA, a bovine platelet lysate raw material for cell culture used in pharmaceutical and regenerative medicine applications. Its lead development effort is ICS-001, an injectable cell scaffold-based angiogenesis therapy for chronic limb-threatening ischemia being advanced through an investigator-initiated clinical trial. CTEX also provides translational and research support intended to help move academic cell therapy seeds from research into clinical application.
- Therapeutic areas
- CardiovascularImmunologyNeurologyGastroenterology
- Modalities
- Cell therapyDeviceBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Hyogo Medical UniversityHyogo Medical University HospitalJapan Agency for Medical Research and Development (AMED)Osaka University Graduate School of Medicine
Beyond the preview
Go deeper on CTEX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CTEX.